Trial Profile
Clinical and microbiological assessment of prulifloxacin in patients with Acute Bacterial Rhinosinusitis (ABRS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2014
Price :
$35
*
At a glance
- Drugs Prulifloxacin (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- Sponsors ACRAF
- 10 Dec 2014 New trial record